Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-26

Clinical Trial Update: Low and High Dose Dextrose Prolotherapy in the Treatment of Lateral Epicondylitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating low and high dose dextrose prolotherapy for lateral epicondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ahi Evran University Education and Research Hospital | Conditions: Lateral Epicondylitis | Phase 4 | Status: COMPLETED